Communiqués Edwards Lifesciences Corporation Börse Stuttgart

Actions

EWL

US28176E1082

Marché Fermé - Börse Stuttgart Autres places de cotation 12:48:43 07/06/2024			Varia. 5j.	Varia. 1 janv.
80,5 ^EUR	0,00%		+0,65%	+16,20%

05/06	Edwards Lifesciences annonce les résultats d'une analyse des données des essais PARTNER portant sur les résultats des patients ayant subi un remplacement valvulaire aortique transcathéter avec un petit anneau	CI
05/06	Transcript : Edwards Lifesciences Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:30 AM

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR	05/06	BU
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader	03/06	PR
Edwards Lifesciences to Sell Critical Care to BD	03/06	BU
Edwards Lifesciences : First Quarter 2024 Fact Sheet	15/05	PU
Edwards lance la valve SAPIEN 3 Ultra RESILIA en Europe avec une technologie pour améliorer la durabilité	09/05	BU
Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	09/05	BU
Edwards Lifesciences: Q1 Earnings Snapshot	25/04	AQ
Edwards Lifesciences Reports First Quarter Results	25/04	BU
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024	18/04	BU
Edwards Lifesciences - Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease without Knowing It	08/04	AQ
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It	07/04	BU
Precedential Federal Circuit Opinion Underscores Tension In Interpretation Of The Safe Harbor Of 35 U.S.C. § 271(e)(1)	03/04	AQ
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR	11/03	BU
EDWARDS LIFESCIENCES TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTHCARE CONFERENCE	26/02	AQ
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference	23/02	BU
Edwards Lifesciences: Q4 Earnings Snapshot	06/02	AQ
Edwards Lifesciences Reports Fourth Quarter Results	06/02	BU
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve	02/02	BU
Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024	30/01	BU
The Party Season Is Upon Us But What Does A Party Look Like To The Unified Patent Court?	02/01	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

Edwards Lifesciences Corporation : L’histoire se poursuit

Le 23 avril 2024 à 10:36